Next Article in Journal
Systemic Adverse Effects Induced by the BNT162b2 Vaccine Are Associated with Higher Antibody Titers from 3 to 6 Months after Vaccination
Next Article in Special Issue
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy
Previous Article in Journal
Immune Response to SARS-CoV-2 Vaccine and Following Breakthrough Omicron Infection in an Autoimmune Patient with Hashimoto’s Thyroiditis, Pernicious Anemia, and Chronic Atrophic Autoimmune Gastritis: A Case Report
Previous Article in Special Issue
Intent to Vaccinate SARS-CoV-2 Infected Children in US Households: A Survey
 
 
Article

Article Versions Notes

Vaccines 2022, 10(3), 452; https://doi.org/10.3390/vaccines10030452
Action Date Notes Link
article pdf uploaded. 15 March 2022 14:05 CET Version of Record https://www.mdpi.com/2076-393X/10/3/452/pdf-vor
article xml file uploaded 16 March 2022 15:51 CET Original file -
article xml uploaded. 16 March 2022 15:51 CET Update https://www.mdpi.com/2076-393X/10/3/452/xml
article pdf uploaded. 16 March 2022 15:51 CET Updated version of record https://www.mdpi.com/2076-393X/10/3/452/pdf
article html file updated 16 March 2022 15:53 CET Original file -
article html file updated 1 August 2022 05:49 CEST Update https://www.mdpi.com/2076-393X/10/3/452/html
Back to TopTop